Syon Capital LLC Has $1.71 Million Holdings in Stryker Co. (NYSE:SYK)

Syon Capital LLC lifted its holdings in shares of Stryker Co. (NYSE:SYK) by 13.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,707 shares of the medical technology company’s stock after purchasing an additional 684 shares during the period. Syon Capital LLC’s holdings in Stryker were worth $1,709,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of SYK. Centaurus Financial Inc. lifted its holdings in Stryker by 10.9% in the fourth quarter. Centaurus Financial Inc. now owns 878 shares of the medical technology company’s stock valued at $263,000 after buying an additional 86 shares during the period. Integrated Advisors Network LLC increased its position in shares of Stryker by 10.6% during the fourth quarter. Integrated Advisors Network LLC now owns 3,342 shares of the medical technology company’s stock worth $1,001,000 after acquiring an additional 321 shares in the last quarter. Virtu Financial LLC bought a new stake in shares of Stryker during the fourth quarter worth about $748,000. Chicago Partners Investment Group LLC increased its position in shares of Stryker by 12.0% during the fourth quarter. Chicago Partners Investment Group LLC now owns 2,447 shares of the medical technology company’s stock worth $753,000 after acquiring an additional 263 shares in the last quarter. Finally, Proathlete Wealth Management LLC bought a new stake in shares of Stryker during the fourth quarter worth about $258,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on SYK shares. Royal Bank of Canada boosted their target price on shares of Stryker from $360.00 to $386.00 and gave the stock an “outperform” rating in a research report on Monday, April 15th. Needham & Company LLC raised shares of Stryker from a “hold” rating to a “buy” rating and set a $392.00 price objective for the company in a research report on Wednesday, May 22nd. The Goldman Sachs Group assumed coverage on shares of Stryker in a research report on Thursday, May 30th. They issued a “neutral” rating and a $372.00 price objective for the company. TD Cowen upped their price objective on shares of Stryker from $365.00 to $400.00 and gave the stock a “buy” rating in a research report on Thursday, April 11th. Finally, Barclays boosted their target price on shares of Stryker from $372.00 to $376.00 and gave the company an “overweight” rating in a research note on Thursday, May 2nd. Four research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $370.58.

Stryker Price Performance

Shares of SYK stock traded up $1.96 during mid-day trading on Friday, hitting $344.98. The company had a trading volume of 746,530 shares, compared to its average volume of 1,214,165. Stryker Co. has a 52-week low of $249.98 and a 52-week high of $361.41. The stock’s 50 day moving average price is $336.88 and its 200-day moving average price is $330.15. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.71 and a quick ratio of 0.99. The company has a market capitalization of $131.42 billion, a P/E ratio of 39.38, a P/E/G ratio of 2.72 and a beta of 0.92.

Stryker (NYSE:SYK) last released its quarterly earnings results on Tuesday, April 30th. The medical technology company reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.36 by $0.14. Stryker had a net margin of 16.03% and a return on equity of 23.05%. The company had revenue of $5.24 billion for the quarter, compared to the consensus estimate of $5.10 billion. During the same quarter in the prior year, the firm earned $2.14 earnings per share. Stryker’s revenue was up 9.7% on a year-over-year basis. Equities research analysts forecast that Stryker Co. will post 11.95 earnings per share for the current year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 31st. Shareholders of record on Friday, June 28th will be given a dividend of $0.80 per share. This represents a $3.20 annualized dividend and a dividend yield of 0.93%. The ex-dividend date is Friday, June 28th. Stryker’s payout ratio is 36.53%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.